Keeneland has announced 10 supplements – headlined by recent Delta Mile winner Dreamer’s Disease – to its November Horses of Racing Age Sale to be held Nov. 17.
The dynamic online catalog for the single-session auction features Daily Racing Form and Equibase past performances along with Thoro-graph and Ragozin sheets, race replays and more. Click here for consolidated past performances and figures for cataloged horses.
Print catalogs and a supplemental catalog for the sale with Equibase past performances for the entrants are now available at Keeneland.
Horses will be available for inspection at Keeneland on Wednesday, Nov. 16. The auction will start the next day at noon.
Highlighting the latest supplements are:
- Dreamer’s Disease, a gate-to-wire winner of the $100,000 Delta Mile on Nov. 5 at Delta Downs to push his career earnings to more than $220,000. Bluewater Sales, agent, consigns the 4-year-old gelding by Laoban.
- Girl Afraid, a 2-year-old filly by Not This Time, was a 3½-length maiden winner at Churchill Downs on Nov. 2. Out of the winning Dominus mare Dominating Woman, Girl Afraid is from the family of Preakness (G1) winner Codex and stakes winner Dance the Slew. She is consigned by Taylor Made Sales Agency, agent, as a racing or broodmare prospect.
- Outofnothingatall finished third in the Sorority Stakes at Monmouth Park in August and is entered in the My Trusty Cat Stakes on Friday at Delta Downs. The 2-year-old Super Saver filly, who is from the family of Canadian Horse of the Year Peaks and Valleys and Grade 3 winner Cryptograph, is consigned by Bluewater Sales, agent, as a racing or broodmare prospect.
- Park On the Nile was a debut winner at Churchill Downs and has earned more than $135,000 in two seasons of racing. A 3-year-old filly by Cairo Prince, Park On the Nile is from the family of Grade 2 winner Park Avenue Ball and stakes winner Beacon Hill Road. She is consigned by Hidden Brook, agent, as a racing or broodmare prospect.
These supplements increase the total number of horses cataloged to the sale to 343.
Additional supplements will be considered until sale date.